For nearly a century we had increasingly strong evidence for a common microbial cause of cancer and autoimmune diseases but now we also have visual proof. A newly developed research microscope can show us in great detail what happens in the blood of individuals who develop these diseases. What it shows is that the key for understanding their cause and cure is the rise, or perhaps better the uprising, of an endogenous microbe in the blood.
Based on the work of Louis Pasteur in the late 19th century the scientific community adopted the concept of monomorphism. This means that microbes always maintain their basic shape as virus, bacterium or fungus. The term pleomorphism, on the other hand, as coined by the French chemist and biologist Antoine Béchamp (1816–1908), refers to the ability of microbes to change from one form into another, similar to a caterpillar changing into a butterfly.
While a causal correlation between cancer and microbes has been shown only in a few rare or animal tumours, several independent researchers have reported the proliferation of certain microbes in all cancer patients. One of the first was the German professor of zoology and microbiology Günther Enderlein who described in 1925 the different stages of a microbe that is normally present in the blood as tiny colloidal protein units.
These protein units appear to originate from the natural breakdown of cellular components and may be essential for healthy blood. In degenerative diseases, especially cancer and autoimmune diseases, but also Chronic Fatigue Syndrome and Fibromyalgia, these protein units grow into increasingly higher bacterial forms and finally into fungi. Conventionally these forms are called Enderlein structures and are the basis of Live Blood Analysis as presently used in natural therapy.
Independently, mostly without knowing of each other’s work, several other researchers – including Royal Raymond Rife, Wilhelm Reich, Virginia Livingston-Wheeler, Alan Cantwell and Gaston Naessens – have described the same phenomenon. Orthodoxy, however, has a dogma that says microbes always have the same form and cannot change from viruses into bacteria and fungi. This is because orthodox microbiologists commonly observe dead stained microbes in dead tissue, or live ones for short periods, instead of live microbes in live tissue at very high magnification over long periods.
Of special interest are experiments of Dr Livingston-Wheeler who injected cultures of pleomorphic organisms into mice. When small amounts were injected then an autoimmune disease developed but higher doses produced tumours or cancer. Accordingly these cancer-forming microbes have often been called cancer viruses or cancer microbes.
The growth cycle of pleomorphics includes a stage as cell-wall-deficient microbes or CWD. These may arise endogenously within our body or arrive from the outside as mycoplasma. Orthodox microbiology does not recognise that CWD can arise endogenously but mycoplasma are known since 1898 as the smallest group of bacteria. The term “myco” indicates fungus-like properties while “plasma” points to the soft shell without a cell wall. They are actually living particles of bacterial nucleic acid and are regarded as being parasites in our body.
Mycoplasma or their spores are so small that, like viruses, they go through bacterial filters and may contaminate blood used for transfusions. Often mycoplasma infections remain symptomless until one suffers a traumatic event or when health deteriorates for some other reason. Because of the missing cell wall mycoplasma do not respond to most antibiotics. Commonly mycoplasma infections are associated with the presence of other pathogenic microbes and parasites.
Of special interest are presently the microbes associated with Lyme disease which can naturally originate from tick bites. The bacteria that cause Lyme disease, the spiral-shaped Borrelia, have been shown to exist in a bacterial as well as in a mycoplasma form and as spores. They also can hide from the immune system by using markers of normal body cells.
Modern Lyme disease started in 1975 as an epidemic in the town of Lyme, Connecticut, close to a biological warfare research laboratory. US government scientists hold a patent on behalf of the US Army for the crystalline mycoplasma fermentans. This semi-synthetic species appears to be much more dangerous than the natural variety (www.publichealthalert.org/Articles/scottforsgren/mycoplasma.htm).
Mycoplasma fermentans is an important agent in several modern diseases which suddenly appeared in epidemic form such as AIDS, Lyme disease, Gulf War Syndrome, and Morgellons disease. Various mycoplasma species are associated with pneumonia, bladder infections, endocrine dysfunctions, gastro-intestinal distress, and other conditions. A key problem with mycoplasma is their disruptive influence on cholesterol and other sterols, and even worse is the toxic effect of the Borrelia spirochete on our lipoproteins, thereby wrecking our fat metabolism.
The microbes of Lyme disease may trigger hundreds of different symptoms and have now been shown to mimic most chronic diseases, especially chronic fatigue conditions, fibromyalgia, and autoimmune diseases in general, but also mental conditions such as schizophrenia, depression, and Alzheimer’s disease. Some of these, including Parkinson’s disease, could be cured by eliminating the mycoplasma infestation (www.samento.com.ec/sciencelib/4lyme/Townsendhowens.html).